Venous Leak Embolization in Patients with Venogenic Erectile Dysfunction via Deep Dorsal Penile Vein Access: Safety and Early Efficacy
CardioVascular and Interventional Radiology · 2023-05 · 46 (5) · 610-616
DOI: 10.1007/s00270-023-03412-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, online erschienen am 22.03.2023. Verfasst von N Diehm und 7 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Institute Central Switzerland, Aarau, Switzerland. Hauptthemen laut MEDLINE: Erectile Dysfunction, Impotence, Vasculogenic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftung Lindenhof Bern, Gefässmedizin Mittelland, SwissIntervention Bern.
Abstract (Originalsprache)
Purpose
This all-comers registry aimed to assess safety and early efficacy of venous embolization in patients with venogenic erectile dysfunction due to venous leak in an unselected cohort.
Methods
Between October 2019 and September 2022, patients with venogenic erectile dysfunction resistant to phosphodiesterase-5-inhibitors were treated with venous embolization using ultrasound-guided anterograde access via a deep dorsal penile vein in a single center. A mix of ethiodized oil and modified cyanoacrylate-based glue n-butyl 2 cyanoacrylate (NBCA) monomer plus methacryloxy-sulpholane monomer (Glubran-2, GEM, Italy) was used as liquid embolic agent. Prior to embolization, venous leak had been verified based on penile duplex sonography and computed tomography cavernosography. Procedural success was defined as technically successful and complete target vein embolization. The primary safety outcome measure was any major adverse event 6 weeks after the procedure. The primary feasibility outcome measure was IIEF-15 (International Index of Erectile Function-15) score improvement ≥ 4 points in ≥ 50% of subjects on 6 weeks follow-up post intervention.
Results
Fifty consecutive patients (mean age 61.8 ± 10.0 years) with severe erectile dysfunction due to venous leak underwent venous embolization. Procedural success was achieved in 49/50 (98%) of patients with no major adverse events on follow-up. The primary feasibility outcome measure at 6 weeks was reached by 34/50 (68%) of patients.
Conclusion
Venous leak embolization via deep dorsal penile vein access using a liquid embolic agent was safe for all and efficacious in the majority of patients with severe venogenic erectile dysfunction on 6 weeks follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vascular Institute Central Switzerland, Aarau, Switzerland.
- University of Applied Sciences Furtwangen, Villingen-Schwenningen, Germany.
- University of Bern, Bern, Switzerland.
- Department of Angiology, University Hospital of Basel, Basel, Switzerland.
- Department of Urology, Hirslanden Clinic Aarau, Aarau, Switzerland.
- University of Bern, Bern, Switzerland. hanno.hoppe@gmail.com.
Förderung
- Stiftung Lindenhof Bern
- Gefässmedizin Mittelland
- SwissIntervention Bern
- GEM Italy
- University of Bern
Zitieren
APA
Diehm, N., Pelz, S., Kalka, C., Keo, H. H., Mohan, V., Schumacher, M. C., Do, D. D., & Hoppe, H. (2023). Venous Leak Embolization in Patients with Venogenic Erectile Dysfunction via Deep Dorsal Penile Vein Access: Safety and Early Efficacy. CardioVascular and Interventional Radiology, 46(5), 610-616. https://doi.org/10.1007/s00270-023-03412-2
Vancouver
Diehm N, Pelz S, Kalka C, Keo HH, Mohan V, Schumacher MC, et al. Venous Leak Embolization in Patients with Venogenic Erectile Dysfunction via Deep Dorsal Penile Vein Access: Safety and Early Efficacy. CardioVascular and Interventional Radiology. 2023;46(5):610-616. doi:10.1007/s00270-023-03412-2
BibTeX
@article{Diehm2023,
author = {Diehm, N and Pelz, S and Kalka, C and Keo, H H and Mohan, V and Schumacher, M C and Do, D D and Hoppe, H},
title = {Venous Leak Embolization in Patients with Venogenic Erectile Dysfunction via Deep Dorsal Penile Vein Access: Safety and Early Efficacy},
journal = {CardioVascular and Interventional Radiology},
year = {2023},
volume = {46},
number = {5},
pages = {610--616},
doi = {10.1007/s00270-023-03412-2}
}
EUVIMED